Viewing StudyNCT00303667



Ignite Creation Date: 2024-05-05 @ 4:45 PM
Last Modification Date: 2024-10-26 @ 9:23 AM
Study NCT ID: NCT00303667
Status: COMPLETED
Last Update Posted: 2017-12-28
First Post: 2006-03-15

Brief Title: Donor Natural Killer Cells and Aldesleukin in Treating Patients wHigh Risk AML Undergoing Donor Stem Cell Transplant
Sponsor: Masonic Cancer Center University of Minnesota
Organization: Masonic Cancer Center University of Minnesota

Key Dates - Follows AllAPIJSON File Order

Start Date: 2005-01
Start Date Type: None
Primary Completion Date: 2011-03
Primary Completion Date Type: ACTUAL
Completion Date: 2011-03
Completion Date Type: ACTUAL
First Submit Date: 2006-03-15
First Submit QC Date: March 15 2006
Study First Post Date: 2006-03-17
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: 2015-07-03
Results First Post Date Type: ESTIMATED
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2017-12-03
Last Update Post Date: 2017-12-28
Last Update Post Date Type: ACTUAL